Richard F. Little, M.D.

Richard F. Little, M.D.

  • Center for Cancer Research
  • National Cancer Institute
HIV and AIDS Malignancy Branch


Dr. Little joined the NCI's Cancer Therapy and Evaluation Program (CTEP) as head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell in April 2007.  His focus is to oversee, review, and coordinate the NCI-sponsored phase III cancer treatment trials in these diseases in an effort to promote practice-changing and definitive clinical trials.

Dr. Little's research interests have focused on immune suppression-related neoplastic disease, investigation of viral targets for oncolytic therapy and immunotherapy, and antiangiogenesis.

For more information about Dr. Little, visit his CTEP website.

Areas of Expertise

Hematologic Cancers
AIDS-related Cancers